A preparing method of high-purity antivenene
A technology for serum preparation and anti-snake venom, applied in the directions of anti-venom, antibodies, medical raw materials derived from mammals, etc., can solve the problems of large allergic side effects, difficult to further improve the purity, and complicated preparation process of snake venom wounds, so as to reduce allergies. Effects of Side Effects Risk
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Publication Date
- 2018-02-16
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
technical field
[0001] The invention relates to a method for preparing biological preparations, in particular to a method for preparing high-purity antivenom serum. Background technique
[0002] Description: Antivenom F(ab') 2 The preparation is a biological agent for the treatment of human venomous snake bites, antivenom F(ab') 2 The purity index of the preparation has a greater impact on the allergic side effects of snake venom patients. The third part of "Chinese Pharmacopoeia" 2015 edition requires antivenom F(ab') 2 The purity index of the preparation is not less than 60%; the anti-toxic antibody is a fragment on the immunoglobulin (IgG); the hyperimmune horse plasma is the plasma preparation prepared from the horse blood collected from the living horse after the snake venom immunization; Snake Venom Serum F(ab') 2 Extracted from ultra-free horse plasma, the immunoglobulin (IgG) in the hyper-free horse plasma contains anti-venom antibodies;
[0003] In the prior art...
Examples
Embodiment
[0049] Product Name: Antivenom F(ab’) 2 High-purity antivenom preparations with a purity greater than 80%;
[0050] Material:
[0051] Puree: ultra-free horse plasma;
[0052] Diluent: water for injection;
[0053] αpH regulator: dilute hydrochloric acid 1mol / L;
[0054] βpH regulator: sodium hydroxide solution, 1mol / L;
[0055] γpH regulator: disodium hydrogen phosphate solution 0.5mol / L;
[0056] Enzymolysis agent: pepsin, specific activity 1:15000, 10mmmol / L, activated by hydrochloric acid;
[0057] Precipitant: octanoic acid, analytically pure;
[0058] Packing: ion exchange chromatography packing, anion-agarose DEAE-Sepharose;
[0059] Filtration membrane: polyethersulfone membrane 0.45μ;
[0060] Ultrafiltration membrane: polyethersulfone membrane 30kD;
[0061] Sterilization membrane: polyethersulfone film 0.2μ;
[0062] A buffer solution: 50mmol / L phosphate solution + 60mmol / L sodium chloride solution;
[0063] B buffer solution: 50mmol / L phosphate solution ...